Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALNT Allient	$29.88 -1.8%	$23.91	$16.91 ▼ $32.95	$505.84M	1.39	116,859 shs	109,429 shs
EYPT EyePoint Pharmaceuticals	$5.68 +1.4%	$5.82	$3.91 ▼ $13.99	$390.85M	1.58	814,541 shs	368,862 shs
FEIM Frequency Electronics	$19.07 -1.7%	$17.11	$8.62 ▼ $20.33	$184.54M	0.38	70,867 shs	188,227 shs
LAB Standard BioTools	$0.92 -3.4%	$1.12	$0.92 ▼ $2.65	$350.04M	1.8	2.14 million shs	2.59 million shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALNT Allient	-1.84%	-7.20%	+41.61%	+12.02%	+5.84%
EYPT EyePoint Pharmaceuticals	+1.43%	-7.34%	-15.35%	-7.64%	-50.48%
FEIM Frequency Electronics	-1.65%	+5.07%	+5.77%	+19.79%	+102.23%
LAB Standard BioTools	-3.45%	-14.67%	-25.68%	-29.11%	-64.42%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALNT Allient	2.6203 of 5 stars	1.3	3.0	1.7	3.5	2.5	2.5
EYPT EyePoint Pharmaceuticals	2.4399 of 5 stars	3.5	2.0	0.0	3.3	1.7	0.6
FEIM Frequency Electronics	2.5159 of 5 stars	0.0	3.0	0.0	3.6	4.2	1.3
LAB Standard BioTools	2.4916 of 5 stars	3.3	0.0	0.0	3.7	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALNT Allient	2.50	Moderate Buy	$31.00	3.75% Upside
EYPT EyePoint Pharmaceuticals	3.00	Buy	$25.38	346.74% Upside
FEIM Frequency Electronics	0.00	N/A	N/A	N/A
LAB Standard BioTools	2.50	Moderate Buy	$2.50	171.27% Upside

Current Analyst Ratings Breakdown

Latest FEIM, ALNT, EYPT, and LAB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/16/2025	EYPT EyePoint Pharmaceuticals	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$30.00 ➝ $26.00
5/8/2025	EYPT EyePoint Pharmaceuticals	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$33.00 ➝ $27.00
5/5/2025	ALNT Allient	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$35.00
5/5/2025	ALNT Allient	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/5/2025	ALNT Allient	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
3/6/2025	EYPT EyePoint Pharmaceuticals	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$33.00 ➝ $33.00
3/6/2025	EYPT EyePoint Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00 ➝ $22.00
2/27/2025	LAB Standard BioTools	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Sector Weight

(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALNT Allient	$516.06M	0.98	$4.36 per share	6.86	$15.52 per share	1.93
EYPT EyePoint Pharmaceuticals	$56.04M	6.97	N/A	N/A	$5.66 per share	1.00
FEIM Frequency Electronics	$65.40M	2.82	$0.95 per share	20.00	$4.20 per share	4.54
LAB Standard BioTools	$169.69M	2.06	N/A	N/A	($1.85) per share	-0.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALNT Allient	$24.10M	$0.59	33.95	16.33	N/A	2.64%	10.80%	4.75%	8/6/2025 (Estimated)
EYPT EyePoint Pharmaceuticals	-$70.79M	-$2.41	N/A	N/A	N/A	-226.57%	-43.01%	-31.63%	8/6/2025 (Estimated)
FEIM Frequency Electronics	$5.59M	$2.41	23.26	∞	N/A	13.02%	21.49%	9.71%	7/21/2025 (Estimated)
LAB Standard BioTools	-$74.66M	-$0.35	N/A	N/A	N/A	-79.92%	-27.05%	-15.52%	7/30/2025 (Estimated)

Latest FEIM, ALNT, EYPT, and LAB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2025	Q1 2025	ALNT Allient	$0.33	$0.46	+$0.13	$0.21	$125.00 million	$134.62 million
5/7/2025	Q1 2025	EYPT EyePoint Pharmaceuticals	-$0.65	-$0.65	N/A	-$0.65	$8.84 million	$24.50 million
3/13/2025	Q3 2025	FEIM Frequency Electronics	N/A	$1.60	N/A	$1.60	N/A	$18.93 million
3/5/2025	Q4 2024	ALNT Allient	$0.28	$0.31	+$0.03	$0.18	$119.72 million	$122.01 million
3/5/2025	Q4 2024	EYPT EyePoint Pharmaceuticals	-$0.54	-$0.64	-$0.10	-$0.64	$11.02 million	$11.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALNT Allient	$0.12	0.40%	+4.55%	20.34%	N/A
EYPT EyePoint Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
FEIM Frequency Electronics	N/A	N/A	N/A	N/A	N/A
LAB Standard BioTools	N/A	N/A	N/A	N/A	N/A

Latest FEIM, ALNT, EYPT, and LAB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/7/2025	ALNT Allient	quarterly	$0.03	0.4%	5/22/2025	5/22/2025	6/5/2025
3/5/2025	ALNT Allient	quarterly	$0.03	0.51%	3/20/2025	3/20/2025	4/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALNT Allient	0.85	4.10	2.18
EYPT EyePoint Pharmaceuticals	N/A	5.50	5.45
FEIM Frequency Electronics	N/A	1.79	0.93
LAB Standard BioTools	N/A	3.76	3.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALNT Allient	61.57%
EYPT EyePoint Pharmaceuticals	99.41%
FEIM Frequency Electronics	58.60%
LAB Standard BioTools	53.74%

Insider Ownership

Company	Insider Ownership
ALNT Allient	14.90%
EYPT EyePoint Pharmaceuticals	4.74%
FEIM Frequency Electronics	26.10%
LAB Standard BioTools	23.16%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALNT Allient	1,950	16.93 million	14.22 million	Optionable
EYPT EyePoint Pharmaceuticals	120	68.81 million	65.02 million	Optionable
FEIM Frequency Electronics	200	9.68 million	7.10 million	Not Optionable
LAB Standard BioTools	620	379.82 million	174.59 million	Optionable

FEIM, ALNT, EYPT, and LAB Headlines

Recent News About These Companies

Paradigm Capital Management Inc. NY Has $435,000 Holdings in Standard BioTools Inc. (NASDAQ:LAB)

May 22 at 8:00 AM | marketbeat.com

Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Balyasny Asset Management L.P.

May 16, 2025 | marketbeat.com

Standard BioTools Inc.: Standard BioTools Reports First Quarter 2025 Financial Results

May 10, 2025 | finanznachrichten.de

Standard BioTools Inc. Earnings Call: Mixed Outlook Amid Challenges

May 7, 2025 | tipranks.com

Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships

May 6, 2025 | msn.com

Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript

May 6, 2025 | seekingalpha.com

Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates

May 6, 2025 | zacks.com

Standard BioTools Reports First Quarter 2025 Financial Results

May 6, 2025 | globenewswire.com

Standard BioTools Q1 2025 Earnings Preview

May 5, 2025 | msn.com

Standard BioTools (LAB) Expected to Announce Earnings on Tuesday

May 1, 2025 | marketbeat.com

Standard BioTools announces new product innovations at AACR 2025

April 24, 2025 | markets.businessinsider.com

Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025

April 24, 2025 | globenewswire.com

Standard BioTools Inc. to Announce First Quarter 2025 Financial Results on May 6, 2025

April 22, 2025 | quiverquant.com

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

April 22, 2025 | globenewswire.com

Casdin Partners Master Fund, L Buys 4,820,959 Shares of Standard BioTools Inc. (NASDAQ:LAB) Stock

March 5, 2025 | insidertrades.com

Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know

March 1, 2025 | uk.finance.yahoo.com

Q4 2024 Standard BioTools Inc Earnings Call

February 27, 2025 | uk.finance.yahoo.com

Standard BioTools downgraded to Sector Weight from Overweight at KeyBanc

February 27, 2025 | markets.businessinsider.com

Standard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call Transcript

February 27, 2025 | msn.com

Keybanc Downgrades Standard BioTools (LAB)

February 27, 2025 | msn.com

Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges

February 27, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEIM, ALNT, EYPT, and LAB Company Descriptions

Allient NASDAQ:ALNT

$29.88 -0.56 (-1.84%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$29.88 +0.01 (+0.02%)

As of 05/23/2025 04:04 PM Eastern

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

EyePoint Pharmaceuticals NASDAQ:EYPT

$5.68 +0.08 (+1.43%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$5.60 -0.08 (-1.41%)

As of 05/23/2025 06:23 PM Eastern

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Frequency Electronics NASDAQ:FEIM

$19.07 -0.32 (-1.65%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$19.14 +0.07 (+0.34%)

As of 05/23/2025 07:56 PM Eastern

Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.

Standard BioTools NASDAQ:LAB

$0.92 -0.03 (-3.45%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$0.96 +0.04 (+4.17%)

As of 05/23/2025 07:55 PM Eastern

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time